HK1205756A1 - Trehalose-containing mammalian cell suspension for prevention of pulmonary embolism formation - Google Patents

Trehalose-containing mammalian cell suspension for prevention of pulmonary embolism formation

Info

Publication number
HK1205756A1
HK1205756A1 HK15106245.3A HK15106245A HK1205756A1 HK 1205756 A1 HK1205756 A1 HK 1205756A1 HK 15106245 A HK15106245 A HK 15106245A HK 1205756 A1 HK1205756 A1 HK 1205756A1
Authority
HK
Hong Kong
Prior art keywords
trehalose
prevention
cell suspension
mammalian cell
pulmonary embolism
Prior art date
Application number
HK15106245.3A
Other languages
English (en)
Chinese (zh)
Inventor
圭樹 和田
土居　雅子
健志 菊地
英司 小林
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1205756A1 publication Critical patent/HK1205756A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
HK15106245.3A 2012-05-08 2015-06-30 Trehalose-containing mammalian cell suspension for prevention of pulmonary embolism formation HK1205756A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012106866A JP5432322B2 (ja) 2012-05-08 2012-05-08 トレハロース含有肺塞栓形成予防用哺乳動物細胞懸濁液
PCT/JP2013/002925 WO2013168403A1 (ja) 2012-05-08 2013-05-02 トレハロース含有肺塞栓形成予防用哺乳動物細胞懸濁液

Publications (1)

Publication Number Publication Date
HK1205756A1 true HK1205756A1 (en) 2015-12-24

Family

ID=49550467

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106245.3A HK1205756A1 (en) 2012-05-08 2015-06-30 Trehalose-containing mammalian cell suspension for prevention of pulmonary embolism formation

Country Status (13)

Country Link
US (1) US10265346B2 (xx)
EP (1) EP2848683B1 (xx)
JP (1) JP5432322B2 (xx)
KR (1) KR20150013154A (xx)
CN (1) CN104271735B (xx)
AU (1) AU2013259255B2 (xx)
CA (1) CA2872460C (xx)
ES (1) ES2614881T3 (xx)
HK (1) HK1205756A1 (xx)
NZ (1) NZ701665A (xx)
SG (1) SG11201407194XA (xx)
TW (1) TWI577379B (xx)
WO (1) WO2013168403A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9084720B2 (en) 2013-05-07 2015-07-21 BioBlast Pharma Ltd. Compositions and methods for treating oculopharyngeal muscular dystrophy
EP2994145B1 (en) 2013-05-07 2023-01-04 Bio Blast Pharma Ltd. Treatment of oculopharyngeal muscular dystrophy by intravenous administration of trehalose
WO2016069173A2 (en) * 2014-09-29 2016-05-06 Cook General Biotechnology Llc Uses of trehalose in cell suspensions
WO2018123628A1 (ja) * 2016-12-28 2018-07-05 ロート製薬株式会社 細胞医薬組成物、疾患治療用キット及び細胞懸濁用溶液
CZ307851B6 (cs) 2017-02-14 2019-06-26 Ústav experimentální medicíny AV ČR, v. v. i. Léčebný přípravek k prevenci a léčení zánětlivých a degenerativních onemocnění
JPWO2023038037A1 (xx) 2021-09-08 2023-03-16

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3253131B2 (ja) 1992-07-24 2002-02-04 洋巳 和田 移植臓器用溶液
CN1188171C (zh) * 1994-06-02 2005-02-09 廓德伦特控股剑桥有限公司 防止各种特质在再水化或熔化时聚集的方法以及由此获得的组合物
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
JPH114682A (ja) * 1997-06-16 1999-01-12 Asahi Medical Co Ltd 有核細胞保存方法、有核細胞保存用組成物及び有核細胞分離方法
FR2787464B1 (fr) 1998-12-21 2003-01-10 Neurotech Compositions pharmaceutiques comprenant des cellules endotheliales immortalisees pour la detection et/ou le traitement des sources angiogeniques et tout particulierement des cancers
US6280718B1 (en) 1999-11-08 2001-08-28 Wisconsin Alumni Reasearch Foundation Hematopoietic differentiation of human pluripotent embryonic stem cells
CA2449589A1 (en) 2001-06-08 2002-12-19 Dnavec Research Inc. Gene transfer into primate embryonic stem cells using vsv-g pseudotyped simian immunodeficiency virus vector
JP5274017B2 (ja) 2005-10-13 2013-08-28 株式会社大塚製薬工場 肝臓保存液
CA2633980A1 (en) * 2005-12-29 2007-07-12 Anthrogenesis Corporation Improved composition for collecting and preserving placental stem cells and methods of using the composition
JP2009296889A (ja) * 2008-06-10 2009-12-24 Foundation For Biomedical Research & Innovation 造血幹細胞の培養方法
KR20210010648A (ko) * 2008-08-20 2021-01-27 안트로제네시스 코포레이션 개선된 세포 조성물 및 그의 제조 방법
US20110208162A1 (en) * 2008-10-24 2011-08-25 Indiana University Rsearch and Technology Corporation Methods for preventing aggregation of adipose stromal cells
JP6027300B2 (ja) * 2009-03-19 2016-11-16 国立大学法人岩手大学 細胞または臓器の保存液および保存方法
JP2010251273A (ja) 2009-04-16 2010-11-04 Norio Sudo 多重管構造蛍光管
JP5341059B2 (ja) * 2010-11-09 2013-11-13 株式会社大塚製薬工場 幹細胞懸濁液

Also Published As

Publication number Publication date
ES2614881T3 (es) 2017-06-02
EP2848683A1 (en) 2015-03-18
US20150118196A1 (en) 2015-04-30
TWI577379B (zh) 2017-04-11
SG11201407194XA (en) 2014-12-30
TW201402136A (zh) 2014-01-16
KR20150013154A (ko) 2015-02-04
EP2848683A4 (en) 2015-10-21
JP5432322B2 (ja) 2014-03-05
AU2013259255A1 (en) 2014-11-27
CN104271735B (zh) 2017-08-04
JP2013233102A (ja) 2013-11-21
CN104271735A (zh) 2015-01-07
CA2872460A1 (en) 2013-11-14
EP2848683B1 (en) 2016-12-21
NZ701665A (en) 2016-09-30
WO2013168403A1 (ja) 2013-11-14
CA2872460C (en) 2018-06-05
US10265346B2 (en) 2019-04-23
AU2013259255B2 (en) 2018-04-05

Similar Documents

Publication Publication Date Title
ZA201502433B (en) Methods of host cell modification
HK1199905A1 (en) Culturing of mesenchymal stem cells
EP2847320A4 (en) OSTEOGEN DIFFERENTIATION OF MESENCHYMAL STEM CELLS
GB2506496B (en) Superhard constructions & methods of making same
HK1205756A1 (en) Trehalose-containing mammalian cell suspension for prevention of pulmonary embolism formation
SG11201503579RA (en) Cell culture med
ZA201403692B (en) Concentration of suspensions
EP2859356A4 (en) WAY CHARACTERIZATION OF CELLS
EP2839017A4 (en) PROCESSES FOR PREPARING PARA-XYLENE FROM BIOMASS
EP2935300A4 (en) NEW POLYMORPHS FROM LNNT
HK1201532A1 (zh) 美托咪定的製備方法
EP2800747A4 (en) POLYMORPHY OF PERAMPANEL
ZA201503034B (en) Method of weight management
IL237118A0 (en) A method for the isolation of populations of different types of pancreatic cells
GB2520899B (en) Method for discriminating differentiation degree of pluripotent stem cell
ZA201302020B (en) Process for preparation of rilpivirine intermediate
HK1223979A1 (zh) 通過毒胡蘿蔔細胞懸浮培養生產毒胡蘿蔔素
EP2817727A4 (en) INFRASTRUCTURE OF A PERSISTENT N UD
GB2505575B (en) Superhard constructions & methods of making same
IL237862A0 (en) Methods to reduce the formation of scale
ZA201501270B (en) Concentration of suspensions
GB201321220D0 (en) Superhard constructions & methods of making same
EP2850064A4 (en) PROCESS FOR THE PREPARATION OF MONTELUKAST SODIUM
PT2928896T (pt) Forma sólida de um derivado de dihidro-pirido-oxazina
EP2888231A4 (en) PROCESS FOR PREPARING CRYSTALLINE ETORICOXIBLE

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220502